| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8662693 | International Journal of Cardiology | 2018 | 7 Pages |
Abstract
The risk of recurrent MCVE in patients with clinically manifest vascular disease has strongly declined in the period between 1996 and 2014. This is only partly attributable to lower prevalence of risk factors, improved medication use and less subclinical atherosclerosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gijs F.N. Berkelmans, Yolanda van der Graaf, Jannick A.N. Dorresteijn, Gert Jan de Borst, Maarten J. Cramer, L. Jaap Kappelle, Jan Westerink, Frank L.J. Visseren, On behalf of the SMART study group On behalf of the SMART study group,